Cargando…

2091. The Impact of Infection Control Cost Reimbursement Policy on Trends in Central Line-Associated Bloodstream Infections

BACKGROUND: In September 2016, the Korean National Health Insurance Service began reimbursing infection control (IC) costs on condition that dedicated doctors and nurses for IC should be allocated in the hospital. We assessed the Impact of IC cost reimbursement policy on trends in central line-assoc...

Descripción completa

Detalles Bibliográficos
Autores principales: Kwon, Ki Tae, Lee, Won Kee, Yu, Mi Hyae, Park, Hyun Ju, Lee, Kyeong Hee, Chae, Hyun Ju
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254123/
http://dx.doi.org/10.1093/ofid/ofy210.1747
_version_ 1783373651689603072
author Kwon, Ki Tae
Lee, Won Kee
Yu, Mi Hyae
Park, Hyun Ju
Lee, Kyeong Hee
Chae, Hyun Ju
author_facet Kwon, Ki Tae
Lee, Won Kee
Yu, Mi Hyae
Park, Hyun Ju
Lee, Kyeong Hee
Chae, Hyun Ju
author_sort Kwon, Ki Tae
collection PubMed
description BACKGROUND: In September 2016, the Korean National Health Insurance Service began reimbursing infection control (IC) costs on condition that dedicated doctors and nurses for IC should be allocated in the hospital. We assessed the Impact of IC cost reimbursement policy on trends in central line-associated bloodstream infections (CLABSI). METHODS: A before-and-after study between pre-intervention (January 2016 to February 2017) and intervention (March 2017 to December 2017) periods was performed in three intensive care units (ICU) at Daegu Fatima Hospital (a 750-bed, secondary care hospital in Daegu, Republic of Korea). The number of dedicated IC nurses increased from 2 to 5 in September 2016 and a first dedicated IC doctor was allocated in March 2017 according to the IC cost reimbursement policy. The enhanced IC team visited ICUs daily and monitor and educate the implementation of CLABSI prevention bundles. The trends between pre-intervention and intervention periods were analyzed by segmented autoregression analysis of an interrupted time series. RESULTS: The average CLABSI rates and total central-line days in the pre-intervention and intervention periods were 3.41 and 2.34 per 1,000 catheter-days; 7,326 and 5,978 days, respectively. Autoregressive analysis revealed that the CLABSI rates per 1,000 catheter days per month in the pre-intervention and intervention periods were -0.256 (95% confidence interval (CI), −0.593, 0.081; P = 0.148) and −0.602 (95% CI, −0.935, −0.268; P = 0.008). The rates of compliance with maximal barrier precaution significantly improved from pre-intervention (55.1%) to intervention (89.4%) period (chi-square test, P < 0.001). The rates of compliance with maintenance bundles also significantly improved from pre-intervention (48.4%) to intervention (69.7%) period (chi-square test, P < 0.001) CONCLUSION: The reimbursement policy for IC cost accelerates the decline in CLABSI rates by increasing the number of IC professionals and improving monitoring, education and implementation of CLABSI prevention bundles. DISCLOSURES: All authors: No reported disclosures.
format Online
Article
Text
id pubmed-6254123
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-62541232018-11-28 2091. The Impact of Infection Control Cost Reimbursement Policy on Trends in Central Line-Associated Bloodstream Infections Kwon, Ki Tae Lee, Won Kee Yu, Mi Hyae Park, Hyun Ju Lee, Kyeong Hee Chae, Hyun Ju Open Forum Infect Dis Abstracts BACKGROUND: In September 2016, the Korean National Health Insurance Service began reimbursing infection control (IC) costs on condition that dedicated doctors and nurses for IC should be allocated in the hospital. We assessed the Impact of IC cost reimbursement policy on trends in central line-associated bloodstream infections (CLABSI). METHODS: A before-and-after study between pre-intervention (January 2016 to February 2017) and intervention (March 2017 to December 2017) periods was performed in three intensive care units (ICU) at Daegu Fatima Hospital (a 750-bed, secondary care hospital in Daegu, Republic of Korea). The number of dedicated IC nurses increased from 2 to 5 in September 2016 and a first dedicated IC doctor was allocated in March 2017 according to the IC cost reimbursement policy. The enhanced IC team visited ICUs daily and monitor and educate the implementation of CLABSI prevention bundles. The trends between pre-intervention and intervention periods were analyzed by segmented autoregression analysis of an interrupted time series. RESULTS: The average CLABSI rates and total central-line days in the pre-intervention and intervention periods were 3.41 and 2.34 per 1,000 catheter-days; 7,326 and 5,978 days, respectively. Autoregressive analysis revealed that the CLABSI rates per 1,000 catheter days per month in the pre-intervention and intervention periods were -0.256 (95% confidence interval (CI), −0.593, 0.081; P = 0.148) and −0.602 (95% CI, −0.935, −0.268; P = 0.008). The rates of compliance with maximal barrier precaution significantly improved from pre-intervention (55.1%) to intervention (89.4%) period (chi-square test, P < 0.001). The rates of compliance with maintenance bundles also significantly improved from pre-intervention (48.4%) to intervention (69.7%) period (chi-square test, P < 0.001) CONCLUSION: The reimbursement policy for IC cost accelerates the decline in CLABSI rates by increasing the number of IC professionals and improving monitoring, education and implementation of CLABSI prevention bundles. DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2018-11-26 /pmc/articles/PMC6254123/ http://dx.doi.org/10.1093/ofid/ofy210.1747 Text en © The Author(s) 2018. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Abstracts
Kwon, Ki Tae
Lee, Won Kee
Yu, Mi Hyae
Park, Hyun Ju
Lee, Kyeong Hee
Chae, Hyun Ju
2091. The Impact of Infection Control Cost Reimbursement Policy on Trends in Central Line-Associated Bloodstream Infections
title 2091. The Impact of Infection Control Cost Reimbursement Policy on Trends in Central Line-Associated Bloodstream Infections
title_full 2091. The Impact of Infection Control Cost Reimbursement Policy on Trends in Central Line-Associated Bloodstream Infections
title_fullStr 2091. The Impact of Infection Control Cost Reimbursement Policy on Trends in Central Line-Associated Bloodstream Infections
title_full_unstemmed 2091. The Impact of Infection Control Cost Reimbursement Policy on Trends in Central Line-Associated Bloodstream Infections
title_short 2091. The Impact of Infection Control Cost Reimbursement Policy on Trends in Central Line-Associated Bloodstream Infections
title_sort 2091. the impact of infection control cost reimbursement policy on trends in central line-associated bloodstream infections
topic Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6254123/
http://dx.doi.org/10.1093/ofid/ofy210.1747
work_keys_str_mv AT kwonkitae 2091theimpactofinfectioncontrolcostreimbursementpolicyontrendsincentrallineassociatedbloodstreaminfections
AT leewonkee 2091theimpactofinfectioncontrolcostreimbursementpolicyontrendsincentrallineassociatedbloodstreaminfections
AT yumihyae 2091theimpactofinfectioncontrolcostreimbursementpolicyontrendsincentrallineassociatedbloodstreaminfections
AT parkhyunju 2091theimpactofinfectioncontrolcostreimbursementpolicyontrendsincentrallineassociatedbloodstreaminfections
AT leekyeonghee 2091theimpactofinfectioncontrolcostreimbursementpolicyontrendsincentrallineassociatedbloodstreaminfections
AT chaehyunju 2091theimpactofinfectioncontrolcostreimbursementpolicyontrendsincentrallineassociatedbloodstreaminfections